Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome

Pediatr Infect Dis J. 2005 Mar;24(3):278-80. doi: 10.1097/01.inf.0000154588.79356.e6.

Abstract

Probiotic agents are increasingly used for the treatment and prevention of a variety of infectious and inflammatory conditions. They are generally safe, but complications of probiotic use can occur. In this report, we describe bacteremia after ingestion of a Lactobacillus rhamnosus GG probiotic tablet in a child with short gut syndrome. We used sequencing of the ribosomal operon region and strain typing with pulsed field electrophoresis of the isolates to show identity between the tablet and bloodstream isolates.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents
  • Bacteremia / complications
  • Bacteremia / diagnosis
  • Bacteremia / drug therapy*
  • Base Sequence
  • Catheterization / adverse effects
  • Catheterization / methods
  • Combined Modality Therapy
  • DNA, Bacterial / analysis
  • Drug Therapy, Combination / therapeutic use
  • Follow-Up Studies
  • Gastrostomy / adverse effects
  • Gastrostomy / methods
  • Gram-Positive Bacterial Infections / complications
  • Gram-Positive Bacterial Infections / diagnosis
  • Gram-Positive Bacterial Infections / drug therapy*
  • Humans
  • Infant
  • Lactobacillus / classification*
  • Male
  • Molecular Sequence Data
  • Polymerase Chain Reaction / methods
  • Probiotics / administration & dosage*
  • Risk Assessment
  • Severity of Illness Index
  • Short Bowel Syndrome / complications
  • Short Bowel Syndrome / diagnosis
  • Short Bowel Syndrome / therapy*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • DNA, Bacterial